TABLE 1.
Characteristics of study patientsa
| Characteristics | Tigecycline group (n = 28) | Nontigecycline group (n = 36) | P value |
|---|---|---|---|
| Age ≥65 yrs | 9 (32) | 10 (28) | 0.918 |
| Male | 6 (21) | 7 (19) | >0.999 |
| BMI <18.5 kg/m2 | 9 (32) | 13 (36) | 0.947 |
| Current smoker or ex-smoker | 4 (14) | 7 (19) | 0.835 |
| Underlying conditions | |||
| Previous tuberculosis treatment | 12 (43) | 21 (58) | 0.329 |
| Previous NTM treatment | 12 (43) | 11 (31) | 0.450 |
| Obstructive pulmonary disease | 3 (11) | 3 (8) | >0.999 |
| Chronic pulmonary aspergillosis | 4 (14) | 5 (14) | >0.999 |
| Symptoms | |||
| Cough | 26 (93) | 28 (78) | 0.193 |
| Sputum | 26 (93) | 31 (86) | 0.650 |
| Hemoptysis | 7 (25) | 9 (25) | >0.999 |
| Radiologic form | |||
| Fibrocavitary disease | 5 (18) | 2 (6) | 0.246 |
| Nodular bronchiectatic disease | 23 (82) | 34 (94) | 0.246 |
| With cavity | 11/23 (31) | 11/34 (39) | 0.642 |
a
Data are presented as number (percentage) or median (interquartile range). BMI, body mass index; NTM, nontuberculous mycobacteria.